Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review

SWALES, John G., HAMM, Gregory, CLENCH, Malcolm and GOODWIN, Richard J.A. (2018). Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review. International Journal of Mass Spectrometry.

Full text not available from this repository.

Abstract

Understanding the biodistribution, metabolism and accumulation of drugs in the body is a fundamental of pharmaceutical research and development. Mass Spectrometry imaging (MSI) has been proven to be a powerful tool to image the unlabelled spatial distribution of exogenous drugs and endogenous metabolites from the surface of tissue sections or small clinical biopsies, aiding the delivery of safe and effective medicines to the market and ultimately benefiting patients. Here we review the current advancements in MSI sample preparation, qualitative and quantitative MSI methodology and drug discovery and development applications. MSI is shown to be supporting R&D from early target identification through to the clinic. In conclusion, we discuss future directions of the technology and the hurdles that need addressing to strengthen its status in multimodal imaging

Item Type:	Article
Research Institute, Centre or Group - Does NOT include content added after October 2018:	Biomedical Research Centre
Identification Number:	https://doi.org/10.1016/j.ijms.2018.02.007
Depositing User:	Carmel House
Date Deposited:	13 Mar 2018 15:55
Last Modified:	18 Mar 2021 11:00
URI:	https://shura.shu.ac.uk/id/eprint/18931

Actions (login required)

View Item

Downloads

Publication Metrics